Imperva Inc (IMPV) PT Lowered to $50.00 at Imperial Capital

Imperva Inc (NYSE:IMPV) had its target price reduced by Imperial Capital from $57.00 to $50.00 in a research report report published on Tuesday morning, Marketbeat.com reports. They currently have an outperform rating on the software maker’s stock.

A number of other brokerages have also recently weighed in on IMPV. BidaskClub cut Imperva from a strong-buy rating to a buy rating in a report on Wednesday, July 5th. ValuEngine cut Imperva from a hold rating to a sell rating in a report on Tuesday, July 11th. Stephens reissued an overweight rating and set a $61.00 price objective (up from $53.00) on shares of Imperva in a report on Thursday, July 13th. Stifel Nicolaus reissued a hold rating and set a $47.00 price objective on shares of Imperva in a report on Friday, July 14th. Finally, Evercore ISI set a $56.00 price objective on Imperva and gave the company a buy rating in a report on Friday, July 28th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company’s stock. The stock has an average rating of Hold and an average price target of $52.34.

Imperva (NYSE IMPV) traded up 0.287% on Tuesday, reaching $43.625. The company’s stock had a trading volume of 54,684 shares. The stock’s 50 day moving average price is $44.05 and its 200 day moving average price is $45.81. Imperva has a 52-week low of $34.40 and a 52-week high of $52.40. The firm’s market cap is $1.48 billion.

Imperva (NYSE:IMPV) last released its quarterly earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.15). Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The business had revenue of $74.44 million during the quarter, compared to analysts’ expectations of $74.30 million. During the same period in the previous year, the business earned ($0.23) EPS. The business’s revenue was up 28.6% on a year-over-year basis. Equities research analysts expect that Imperva will post $0.81 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was originally reported by Stock Observer and is the property of of Stock Observer. If you are reading this piece of content on another website, it was copied illegally and republished in violation of United States and international copyright & trademark law. The original version of this piece of content can be read at https://www.thestockobserver.com/2017/10/13/imperva-inc-impv-pt-lowered-to-50-00-at-imperial-capital.html.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the firm’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the transaction, the director now directly owns 99,598 shares in the company, valued at approximately $4,341,476.82. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 2.20% of the stock is owned by company insiders.

Hedge funds have recently modified their holdings of the company. Ameritas Investment Partners Inc. bought a new stake in shares of Imperva in the 1st quarter worth approximately $102,000. Migdal Insurance & Financial Holdings Ltd. grew its position in shares of Imperva by 26.2% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock worth $201,000 after buying an additional 866 shares during the last quarter. Amalgamated Bank bought a new stake in shares of Imperva in the 2nd quarter worth approximately $206,000. Principal Financial Group Inc. bought a new stake in shares of Imperva in the 2nd quarter worth approximately $223,000. Finally, KCG Holdings Inc. bought a new stake in shares of Imperva in the 1st quarter worth approximately $201,000. Hedge funds and other institutional investors own 92.72% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply